News
Hutchmed China said in an update on Wednesday that it has completed patient enrollment in its phase three ‘Sanovo’ trial in China testing a combination of ‘Orpathys’, or savolitinib, and ‘Tagrisso’, ...
Global science-led biopharmaceutical company AstraZeneca Philippines has signed a memorandum of understanding (MOU) with the ...
Elizabeth Bodin is very excited about the FDA-approved FluMist, a nasal spray that can be ordered online and delivered to ...
FluMist is the only nasal spray flu vaccine in the U.S. that is FDA approved for at home use. It can be self-administered by ...
A new option for a flu vaccine has been approved, and it can be ordered online. It is the only nasal spray flu vaccine in the ...
MANILA, Philippines - The government is partnering with the local subsidiary of multinational pharmaceutical company ...
Merck's ifinatamab deruxtecan wins FDA Breakthrough Therapy status for treating adults with extensive-stage small cell lung ...
FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at ...
The Philippine Economic Zone Authority (Peza) has sealed a deal with AstraZeneca Pharmaceuticals (Phils.) to establish the country’s first pharma innovation hub, a flagship project aimed at boosting ...
FluMist, a nasal spray flu vaccine made by AstraZeneca, is now available for at-home use through a service called FluMist ...
Oncology sales comprise more than 25% of Pfizer’s total revenues. Its oncology revenues grew 9% in the first half of 2025, ...
AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results